Is Fibroblast Growth Factor 23 the New Biomarker for Cardiovascular Mortality in Chronic Kidney Disease Patients?

Is Fibroblast Growth Factor 23 the New Biomarker for Cardiovascular Mortality in Chronic Kidney Disease Patients? Am J Nephrol. 2016 Dec 23;45(2):146-148 Authors: Filler G, McIntyre C PMID: 28006763 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/28006763?dopt=Abstract

Source: American Journal of Nephrology - December 22, 2016 Category: Urology & Nephrology Authors: Filler G, McIntyre C Tags: Am J Nephrol Source Type: research

More News: Cardiology | Cardiovascular | Chronic Kidney Disease | Heart | Urology & Nephrology